The self-assembling camptothecin-tocopherol prodrug: An effective approach for formulating camptothecin
Biomaterials, ISSN: 0142-9612, Vol: 62, Page: 176-187
2015
- 64Citations
- 38Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations64
- Citation Indexes64
- 64
- CrossRef45
- Captures38
- Readers38
- 38
Article Description
Camptothecin (CPT) is a potent antitumor agent and functions via inhibiting the activity of topoisomerase I during DNA replication. However, the clinical application of CPT has been greatly hindered by its extremely poor solubility, the instability of its active lactone ring in blood stream, as well as the non-specific toxicity to normal tissues. In addition, most of the formulations developed so far are not applicable for formulating CPT. In this study, two novel CPT prodrugs were developed by conjugating CPT to α-tocopherol via a carbonate ester bond (CPT-VE) or disulfide linkage (CPT-S-S-VE). Both CPT prodrugs were able to self-assemble into nanofibers with the facilitation of a PEG 5K -Fmoc-VE 2 -based nanomicellar carrier. Both prodrug nanoassemblies exhibited excellent stability. Fluorescence quenching, UV absorbance, and FT-IR studies demonstrated strong interactions between carrier and prodrugs, including hydrophobic interaction, π–π stacking, as well as hydrogen bonding. NMR studies suggested that prodrugs were successfully incorporated into PEG 5K -Fmoc-VE 2 during self-assembly process. In vitro, PEG 5K -Fmoc-VE 2 /CPT-S-S-VE presented significantly higher level of cytotoxicity on tumor cells compared to PEG 5K -Fmoc-VE 2 /CPT-VE. Biodistribution study showed that CPT-S-S-VE formulated in PEG 5K -Fmoc-VE 2 micelles was effectively converted to parent CPT following delivery to tumor tissues. Finally, PEG 5K -Fmoc-VE 2 /CPT-S-S-VE nanofibers showed superior tumor growth inhibition in an aggressive murine breast cancer model (4T1.2).
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0142961215005086; http://dx.doi.org/10.1016/j.biomaterials.2015.05.046; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84930793784&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/26057133; https://linkinghub.elsevier.com/retrieve/pii/S0142961215005086; https://dx.doi.org/10.1016/j.biomaterials.2015.05.046
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know